Artemis Medicare Services Ltd
- Market Cap ₹ 3,409 Cr.
- Current Price ₹ 245
- High / Low ₹ 350 / 208
- Stock P/E 39.1
- Book Value ₹ 60.9
- Dividend Yield 0.18 %
- ROCE 14.6 %
- ROE 12.9 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 33.0% CAGR over last 5 years
Cons
- Stock is trading at 4.02 times its book value
- Company has a low return on equity of 11.7% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 547 | 565 | 408 | 555 | 737 | 879 | 937 | 969 | |
| 481 | 503 | 373 | 487 | 643 | 746 | 785 | 812 | |
| Operating Profit | 66 | 62 | 35 | 68 | 94 | 133 | 152 | 157 |
| OPM % | 12% | 11% | 9% | 12% | 13% | 15% | 16% | 16% |
| 2 | 4 | 7 | 3 | 7 | 7 | 33 | 36 | |
| Interest | 11 | 13 | 13 | 12 | 20 | 31 | 32 | 31 |
| Depreciation | 20 | 23 | 22 | 22 | 31 | 40 | 45 | 46 |
| Profit before tax | 37 | 31 | 8 | 37 | 51 | 68 | 108 | 116 |
| Tax % | 45% | 36% | 18% | 16% | 25% | 28% | 24% | |
| 20 | 19 | 6 | 31 | 38 | 49 | 82 | 87 | |
| EPS in Rs | 0.97 | 1.49 | 0.49 | 2.40 | 2.88 | 3.62 | 6.00 | 6.32 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 16% | 12% | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 19% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 33% |
| 3 Years: | 37% |
| TTM: | 56% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 72% |
| 3 Years: | 57% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 12% |
| Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 14 | 14 |
| Reserves | 280 | 300 | 307 | 346 | 390 | 435 | 824 |
| 114 | 113 | 147 | 201 | 286 | 320 | 290 | |
| 147 | 160 | 133 | 149 | 216 | 203 | 229 | |
| Total Liabilities | 554 | 586 | 600 | 710 | 905 | 972 | 1,357 |
| 381 | 393 | 383 | 489 | 605 | 719 | 745 | |
| CWIP | 49 | 56 | 81 | 64 | 95 | 33 | 40 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 124 | 137 | 136 | 157 | 205 | 219 | 572 | |
| Total Assets | 554 | 586 | 600 | 710 | 905 | 972 | 1,357 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 40 | 56 | 27 | 60 | 127 | 109 | 146 | |
| -50 | -26 | -37 | -107 | -158 | -88 | -385 | |
| 14 | -27 | 18 | 44 | 38 | -29 | 267 | |
| Net Cash Flow | 5 | 2 | 8 | -3 | 7 | -8 | 27 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 52 | 49 | 49 | 48 | 46 | 39 | 39 |
| Inventory Days | |||||||
| Days Payable | |||||||
| Cash Conversion Cycle | 52 | 49 | 49 | 48 | 46 | 39 | 39 |
| Working Capital Days | -51 | -36 | -36 | -26 | -43 | -27 | -28 |
| ROCE % | 10% | 4% | 10% | 11% | 14% | 15% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
17 Oct - Of allotment of 3,06,000 equity shares of face value of INR 1/- each against exercise of vested options under Artemis Medicare Management Stock Option Plan-2021
-
Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window
9 Oct - No re-lodged physical share transfer requests under SEBI special window for Sept 1–30, 2025; report dated Oct 9, 2025.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Oct - Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2025
- Closure of Trading Window 29 Sep
-
Announcement under Regulation 30 (LODR)-Change in Management
18 Sep - Artemis Medicare appointed Rudra Narayan Acharjee as Head-Investor Relations, M&A and Organization Growth Strategy, effective Sept 18, 2025.
Annual reports
Concalls
-
Aug 2025TranscriptNotesPPT
-
May 2025TranscriptNotesPPT
-
Feb 2025TranscriptNotesPPT
-
Nov 2024TranscriptNotesPPT
-
Aug 2024TranscriptNotesPPT
-
May 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
Business Profile[1]
Promoted by Apollo Tyres Group, Artemis Medicare Services Ltd manages multi-specialty hospitals in Haryana under the brand Artemis Hospitals. The company provides a comprehensive range of advanced medical and surgical services across specialties such as cardiology, oncology, orthopedics, neurology, nephrology, gastroenterology, and critical care.